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Purpose: Next-generation sequencing (NGS) has revolutionized systems-based analysis of cellular pathways. The goals
of this study are to compare NGS-derived retinal transcriptome profiling (RNA-seq) to microarray and quantitative reverse
transcription polymerase chain reaction (qRT–PCR) methods and to evaluate protocols for optimal high-throughput data
analysis.
Methods: Retinal mRNA profiles of 21-day-old wild-type (WT) and neural retina leucine zipper knockout (Nrl−/−) mice
were generated by deep sequencing, in triplicate, using Illumina GAIIx. The sequence reads that passed quality filters
were analyzed at the transcript isoform level with two methods: Burrows–Wheeler Aligner (BWA) followed by ANOVA
(ANOVA) and TopHat followed by Cufflinks. qRT–PCR validation was performed using TaqMan and SYBR Green
assays.
Results: Using an optimized data analysis workflow, we mapped about 30 million sequence reads per sample to the mouse
genome (build mm9) and identified 16,014 transcripts in the retinas of WT and Nrl−/− mice with BWA workflow and
34,115 transcripts with TopHat workflow. RNA-seq data confirmed stable expression of 25 known housekeeping genes,
and 12 of these were validated with qRT–PCR. RNA-seq data had a linear relationship with qRT–PCR for more than four
orders of magnitude and a goodness of fit (R2) of 0.8798. Approximately 10% of the transcripts showed differential
expression between the WT and Nrl−/− retina, with a fold change ≥1.5 and p value <0.05. Altered expression of 25 genes
was confirmed with qRT–PCR, demonstrating the high degree of sensitivity of the RNA-seq method. Hierarchical
clustering of differentially expressed genes uncovered several as yet uncharacterized genes that may contribute to retinal
function. Data analysis with BWA and TopHat workflows revealed a significant overlap yet provided complementary
insights in transcriptome profiling.
Conclusions: Our study represents the first detailed analysis of retinal transcriptomes, with biologic replicates, generated
by  RNA-seq  technology.  The  optimized  data  analysis  workflows  reported  here  should  provide  a  framework  for
comparative investigations of expression profiles. Our results show that NGS offers a comprehensive and more accurate
quantitative and qualitative evaluation of mRNA content within a cell or tissue. We conclude that RNA-seq based
transcriptome characterization would expedite genetic network analyses and permit the dissection of complex biologic
functions.
Next-generation  sequencing  (NGS)  technology  has
launched a new era of enormous potential and applications in
genomic and transcriptomic analyses [1-3]. With continued
cost reductions and improved analytical methods, NGS has
begun to have a direct impact on biomedical discovery and
clinical outcome [4-6]. NGS has enabled “meta-genomic”
studies to survey the genomes of organisms in a particular
ecosystem  [7],  and  decode  the  entire  genomes  of  species
ranging from bacteria [8,9] and viruses [10] to humans [11].
Whole-genome sequencing has made it possible to investigate
genetic variations [12], global DNA methylation [13], and in
vivo analysis of targets of DNA-binding proteins [14,15].
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Deep  sequencing  of  RNA  with  NGS  (called  “RNA-seq”)
allows a comprehensive evaluation and quantification of all
subtypes  of  RNA  molecules  expressed  in  a  cell  or  tissue
[16]. RNA-seq technology can detect transcripts expressed at
low levels [17] and permit the identification of unannotated
transcripts  and  new  spliced  isoforms  [16,18].  The  issues
related to cross-hybridization and detection levels that limit
the  accuracy  of  gene  expression  estimates  by  microarray
technology are not relevant to the data obtained with RNA-
seq [19]. Visualization of mapped sequence reads spanning
the splice junctions can also reveal novel splice forms of
annotated genes in the mouse retina, which was not possible
with earlier hybridization-based technologies. With a steady
reduction in the costs of NGS, RNA-seq is now emerging as
a  method  of  choice  for  comprehensive  transcriptome
profiling.
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3034The vertebrate retina exhibits a highly organized laminar
structure  that  captures,  integrates,  and  transmits  visual
information to the brain for further processing. Photoreceptors
constitute more than 70% of the retinal cells and convert light
into electrical signals [20]. Rod photoreceptors mediate dim
light vision and can detect a single photon of light, while cone
photoreceptors  are  responsible  for  daylight  vision,  color
perception,  and  visual  acuity  [21,22].  Impairment  of
photoreceptor function leads to retinal degeneration with a
more common pattern of rod death preceding the death of
cones [23-25]. The neural retina leucine zipper (Nrl) gene
encodes  a  basic-motif  leucine  zipper  transcription  factor
necessary for determining rod photoreceptor cell fate and
functional maintenance [26]. The Nrl−/− mouse, generated by
creating a loss of function mutation in Nrl, has a cone-only
retina that serves as a useful model for studies of cone biology
[26-28].
Several previous investigations have elucidated the gene
expression landscape specific to whole retina or retinal cell
types and during development or aging. Serial analysis of gene
expression [29-31] and cDNA eye gene arrays [32-36] were
initially  used  to  determine  signatures  of  retinal  gene
expression. Oligonucleotide microarrays have since allowed
a  more  comprehensive  approach  to  expression  profiling
[37-41]. Microarray analyses of flow-sorted photoreceptors
and single cells from dissociated retinas [42-44] have begun
to reveal new insights into regulatory networks. Application
of NGS technology greatly expands the power of expression
profiling by identifying all transcripts and spliced isoforms in
the tissue or cell type of interest.
Here, we have used the power of NGS-based RNA-seq
analysis to investigate in depth the transcriptome of wild-type
(WT) and Nrl−/− retinas and identified a set of differentially
expressed genes and spliced isoforms. We have also taken
advantage of the knowledge about Nrl−/− mice to optimize
workflows for data analysis and compared our results with
those  obtained  with  microarray  methods  and  quantitative
reverse transcription polymerase chain reaction (qRT–PCR)
analysis. Our studies illustrate that RNA-seq offers a more
complete,  accurate,  and  relatively  faster  approach  for
comparative  and  comprehensive  analysis  of  retinal
transcriptomes  and  for  discovering  novel  transcribed
sequences. Our validated data analysis workflow should also
be beneficial for similar studies by other investigators. Raw
data and workflow are available on the N-NRL/NEI website.
METHODS
Animals and tissue collection: All investigations on mice were
approved by the Animal Care and Use Committee of the
National  Eye  Institute  and  followed  the  tenets  of  the
Declaration of Helsinki. C57Bl/6J (referred to as wild type,
WT) and Nrl−/− (on C57Bl/6J background [26]) mice were
euthanized with CO2 inhalation. The retinas were excised
rapidly, frozen on dry ice, and stored at −80 °C.
RNA isolation: Fresh frozen mouse retinas were lysed with a
mortar and pestle in TRIzol Reagent, and total RNA was
isolated according to the manufacturer’s protocol (Invitrogen,
Carlsbad, CA). RNA quality and quantity were assessed with
the RNA 6000 Nano Kit (Agilent, Santa Clara, CA).
NGS library construction: Whole retinal RNA samples were
independently processed from three wild-type and three Nrl
−/− mice at P21. Total RNA (1 μg) was used with the TruSeq
mRNA-seq Sample Preparation Kit (Illumina, San Diego,
CA) to construct cDNA libraries. The quality of the libraries
was  verified  using  the  DNA-1000  Kit  (Agilent)  and
quantitation performed with qRT–PCR using ABI 7900HT
(Life  Technologies,  Carlsbad,  CA),  as  suggested  in  the
Sequencing  Library  qRT–PCR  Quantification  Guide
(Illumina). Gene Expression Master Mix (Life Technologies)
was used for the qRT–PCR reactions, and a titration of phiX
control libraries was employed as the quantification standard.
Illumina  sequencing:  Each  cDNA  library  (10  pM)  was
independently loaded into one flow cell lane, and single-read
cluster generation proceeded using the TruSeq SR Cluster
Generation Kit v5 (Illumina). Sequencing-by-synthesis (SBS)
of 70-nucleotide length was performed on a Genome Analyzer
IIx  running  SCS2.8  software  using  SBS  v4  reagents
(Illumina). Base calling and chastity filtering were performed
using RTA (real-time analysis with SCS2.8).
Burrows–Wheeler  transform-based  short  read  aligner
analysis  workflow:  Burrows–Wheeler  Transform  Aligner
(BWA) [45] was used to align RNA-seq reads against the
mouse  reference  genome  (build  mm9),  downloaded  and
indexed  from  the  University  of  California  Santa  Cruz
(UCSC)  genome  browser  database  [46].  The  resulting
sequence  alignment/map  files  were  imported  into  Partek
Genomics Suite (Partek Inc., St. Louis, MO) to compute raw
and fragments per kilobase of exon model per million mapped
(FPKM) reads normalized expression values of the transcript
isoforms defined in the UCSC refFlat file. A stringent filtering
criterion of FPKM value 1.0 (equivalent to one transcript per
cell [16]) in at least one out of six samples was used to obtain
expressed  transcripts.  The  FPKM  values  of  the  filtered
transcripts were log-transformed using log2 (FPKM+offset)
with an offset=1.0. ANOVA (ANOVA) was then performed
on the log-transformed data of the two groups (WT and Nrl−/
−) to generate fold change and p values for each transcript. Y-
chromosome transcripts were filtered out along with non-
coding  (nc)  RNAs,  mitochondrial  DNA  coded  genes,
pseudogenes,  and  predicted  protein-coding  genes.
Differentially expressed mRNA isoforms were filtered for a
fold change cutoff of 1.5 and p-value cutoff of 0.05. These
criteria  were  implemented  to  enable  a  comparison  with
previous  expression  studies.  Hierarchical  clustering  was
performed  using  Cluster  3.0  software  [47].  We  used
uncentered correlation as the distance metric. Heatmaps and
dendrograms were generated using JavaTreeView software
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3035[48].  Aligned  reads  were  visualized  using  the  Integrated
Genomics Viewer (IGV) [49].
TopHat/Cufflinks-based analysis workflow: Raw reads that
passed  the  chastity  filter  threshold  were  mapped  using
TopHat [50] to identify known and novel splice junctions and
to  generate  read  alignments  for  each  sample.  Genomic
annotations were obtained from Ensembl in gene transfer
format (GTF). Splice junctions from the six samples were
combined into a master junctions file that was used as an input
file for the second iteration of TopHat mapping. The transcript
isoform  level  and  gene  level  counts  were  calculated  and
FPKM normalized using Cufflinks. An FPKM filtering cutoff
of 1.0 in at least one of the six samples was used to determine
expressed transcripts. Differential transcript expression was
then  computed  using  Cuffdiff.  The  resulting  lists  of
differentially expressed isoforms were filtered and sorted into
the following categories: protein coding mRNA transcripts
and ncRNA transcripts.
qRT–PCR  analysis:  Reverse  transcription  (RT)  reactions
were  performed  using  oligo(dT)20  with  SuperScript  II
reagents (Life Technologies) according to the manufacturer’s
protocol. cDNA synthesized from 2 μg of total RNA (1 μg for
minus RT controls) was diluted to 100 μl (fivefold dilution),
and from this 1 μl was used for each qRT–PCR reaction. The
qRT–PCR reactions were performed in triplicate for TaqMan
assays  or  in  duplicate  for  the  SYBR  assays,  using  three
biologic  replicates  per  genotype,  on  a  7900HT  Genetic
Analyzer  (Life  Technologies).  TaqMan  assays  were
performed using TaqMan Gene Expression Master Mix and
TaqMan Gene Expression Assays (Life Technologies) for
genes listed in Table 1. The SYBR Green assays (Table 2)
were performed using Power SYBR Green Master Mix (Life
Technologies) and oligonucleotides at a final concentration of
200 nM. Oligonucleotides were designed using the Primer3
PCR Primer Design Tool [51] and synthesized by Integrated
DNA  Technologies  (Coralville,  IA).  To  eliminate
complications due to contaminating genomic DNA in the
RNA samples, qRT–PCR reactions were also performed with
minus-RT  control,  using  hypoxanthine  guanine
phosphoribosyl  transferase  (Hprt)  primer  pairs  that  can
TABLE 1. TAQMAN ASSAYS EMPLOYED FOR QRT–PCR VALIDATION
TaqMan assay ID Gene symbol Gene name
Mm00607939_s1 Actb actin, b
Mm00504628_m1 Arr3 arrestin 3, retinal
Mm00437764_m1 B2m b-2 microglobulin
Mm00474799_m1 Cadm3 cell adhesion molecule 3
Mm00432322_m1 Casp7 caspase 7
Mm00833234_m1 Cnga1 cyclic nucleotide gated channel a 1
Mm00489232_m1 Cngb3 cyclic nucleotide gated channel b 3
Mm00656724_m1 Egr1 early growth response 1
Mm00442411_m1 Esrrb estrogen related receptor, b
Mm00438796_m1 Eya1 eyes absent 1 homolog (Drosophila)
Mm00445225_m1 Fabp7 fatty acid binding protein 7, brain
Mm99999915_g1 Gapdh glyceraldehyde-3-phosphate dehydrogenase
Mm00492388_g1 Gnat1 guanine nucleotide binding protein, a transducing 1
Mm00492394_m1 Gnat2 guanine nucleotide binding protein, a transducing 2
Mm01197698_m1 Gusb glucuronidase, b
Mm01318747_g1 Hprt1 hypoxanthine guanine phosphoribosyl transferase 1
Mm00833431_g1 Hsp90ab1 heat shock protein 90 kDa a, class B member 1
Mm01340839_m1 Mef2c myocyte enhancer factor 2C
Mm00443299_m1 Nr2e3 nuclear receptor subfamily 2, group E, member 3
Mm00476550_m1 Nrl neural retina leucine zipper gene
Mm00524018_m1 Nxnl1 nucleoredoxin-like 1
Mm00433560_m1 Opn1mw opsin 1 (cone pigments), medium-wave-sensitive
Mm00432058_m1 Opn1sw opsin 1 (cone pigments), short-wave-sensitive
Mm00476679_m1 Pde6b phosphodiesterase 6B, cGMP, rod receptor, b
Mm00473920_m1 Pde6c phosphodiesterase 6C, cGMP specific, cone, a prime
Mm01225301_m1 Pgk1 phosphoglycerate kinase 1
Mm00519814_m1 Reep6 receptor accessory protein 6
Mm00520345_m1 Rho Rhodopsin
Mm00524993_m1 Rorb RAR-related orphan receptor b
Mm01612986_gH Rpl13a ribosomal protein L13A
Mm02601831_g1 Rps26 ribosomal protein S26
Mm00774693_g1 Sall3 sal-like 3 (Drosophila)
Mm01249143_g1 Socs3 suppressor of cytokine signaling 3
Mm01277045_m1 Tbp TATA box binding protein
Mm00726185_s1 Tubb4 tubulin, b 4
Mm01198158_m1 Ubc ubiquitin C
Mm00457574_m1 Wisp1 WNT1 inducible signaling pathway protein 1
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3036differentiate between mRNA and genomic DNA (data not
shown). Differential expression analysis was performed using
the ddCt method [52], with the geometric average of actin,
beta (ActB) and Hprt as the endogenous controls [53].
RESULTS
Sequencing run summary: Six libraries of P21 retinal cDNA
(three each from WT and Nrl−/−) were sequenced to obtain 35
to 49 million raw sequence reads per sample (Table 3). Of
these, 75.8% to 82.7% reads passed the RTA chastity filter
and  were  used  for  subsequent  Burrows–Wheeler  Aligner
(BWA) and TopHat analysis workflows (Figure 1). Due to
TopHat workflow’s power to map across splice junctions, the
workflow consistently yielded 6 to 7 million more alignments
per sample when compared to BWA.
BWA  workflow:  Based  on  the  BWA  analysis  workflow,
16,014 transcripts were detected with a normalized FPKM
value greater than 1.0 in any of the six samples. Transcripts
were filtered based on whether they were mRNAs or ncRNAs.
Of the 15,142 mRNA transcripts, only 1,422 met our criteria
of differential expression of having a fold change greater than
1.5  and  a  p-value  less  than  0.05  (Table  4).  Of  the  1,422
differentially  expressed  mRNA  transcripts  (DETs)
representing 1,218 unique genes, 551 were downregulated in
Nrl−/− (including rod-specific genes) retinas, and 871 were
TABLE 2. SYBR GREEN ASSAYS EMPLOYED FOR QRT–PCR VALIDATION
Gene symbol Gene name Forward Reverse
Abca13 (Exon
53/55)
ATP-binding cassette, sub-family A (ABC1), member 13 GACCTTCTGAGATGGCCAAG TTAACTCCAAGGAGCCCAAA
Abca13 (Exon
58/60)
ATP-binding cassette, sub-family A (ABC1), member 13 CGGTACCTCTGGCAAACAAT GGAAATGGAGCTTCAAGCAG
Acoxl acyl-CoA oxidase-like TGCTGTATGGAACGAAGCTG TGTGGAATGTTGAAGGCAGA
Akt3 thymoma viral proto-oncogene 3 CATCTGAAACAGACACCCGATA GTCCGCTTGCAGAGTAGGAG
Cadm3 cell adhesion molecule 3 AGGGATTGTGGCTTTCATTG CTAGGGGCTCAGGAGTTGTG
Ccdc24 coiled-coil domain containing 24 TGTCACATGTTGCAGAACGA TCTAAGGCTGGGAATGGATG
Cd8a CD8 antigen, alpha chain GACATCTCAGCCCCAGAGAC GCTTGCCTTCCTGTCTGACT
Cox5b cytochrome c oxidase, subunit Vb CGTCCATCAGCAACAAGAGA ATAACACAGGGGCTCAGTGG
Ctss cathepsin S TAAAGGGCCTGTCTCTGTGG GCCATCCGAATGTATCCTTG
Drd4 dopamine receptor D4 AGACTGCCCACCTCCCTTAC AAGAAAGGCGTCCAACACAC
Dynlt3 dynein light chain Tctex-type 3 TTGATGGAGTTTTGGGTGGT GGTACGGTTCTCCCATCTGA
Hr hairless GCCCTCTCTGCTCAGCTCTA CGGACCACACCGTCTAAGTT
Klf9 Kruppel-like factor 9 ACAGTGGCTGTGGGAAAGTC CATGCTTGGTGAGATGGTCA
Klhl3 kelch-like 3 GAGCACTGGGAGGAGCTATG AGGAGGTTGGTCTGCTGAGA
Klhl33 kelch-like 33 AGCTTCTTCCCTTTGGTGGT CTACAGCCACCGCTGACATA
Neurod1 neurogenic differentiation 1 GCGTTGCCTTAGCACTTCTT AGGAGTGTGTGTTGGCATTT
Nipal1 NIPA-like domain containing 1 CCCACAAGAGGGAGAAGTCA GTAAACAGGCTTCCGTTCCA
Pip5k1a phosphatidylinositol-4-phosphate 5-kinase, type 1 alpha GGGGAACACAGAGCACAAGT GGTCTTCTGAGGCTCACTGC
Plekhf2 pleckstrin homology domain containing, family F (with
FYVE domain) member 2
GTTGTCGGGTTCGACTGGA TGCGTCTAGTATTCGCCTCAC
Rab18 RAB18, member RAS oncogene family TGCACGCAAGCATTCTATGT GGCTCTCTTCCCTGTGTGAC
Rgs22 regulator of G-protein signaling 22 GCCCAGAAGATCCTTGAACA CGCCTTGTCCTCTTCTGTGT
Rpgrip1 retinitis pigmentosa GTPase regulator interacting protein 1 GCCATGCTACATGCTCAAGA TTTGGATGGCCTGGTTTCTA
Sema7a sema domain, immunoglobulin domain (Ig), and GPI
membrane anchor, (semaphorin) 7A
TCTACAGCTCCCAACGATCA GCTCACAGCTCTGTTCCACA
Txnip thioredoxin interacting protein TATGTACGCCCCTGAGTTCC GTTCCCCGCTGTAGAGACTG
Wisp1 WNT1 inducible signaling pathway protein 1 GCTCTACCACCTGTGGCCTA ACAGCCTGCGAGAGTGAAGT
Wscd2 WSC domain containing 2 TCTGCATCAAGACCCATGAA ACGGTCTTGCCAAACTTGAG
TABLE 3. SUMMARY OF ILLUMINA BASE CALLING AND ALIGNMENTS
Genotype WT WT WT Nrl−/− Nrl−/− Nrl−/−
  Sample 1 Sample 2 Sample 3 Sample 1 Sample 2 Sample 3
Total reads 35,872,080 41,785,800 49,076,400 46,689,240 48,480,240 48,656,040
PF Reads 29,603,280 33,251,160 37,642,800 36,472,800 37,119,960 36,823,320
  82.7% 79.7% 76.9% 78.2% 76.7% 75.8%
BWA alignments 24,992,271 27,922,997 32,085,799 30,960,565 31,374,578 31,257,335
TopHat alignments 30,769,939 34,177,120 39,222,596 38,289,469 38,744,790 38,593,533
        Each of the 3 week old WT and Nrl−/− retina sample was sequenced on a separate lane of the Illumina GAIIx flow cell to obtain
        35 to 49 million raw reads. Over 75% of the raw reads passed Illumina’s read chastity threshold to yield 29 to 37 million usable
        PF reads. TopHat mapping always gave significantly more alignments than BWA because of its ability to map across the splice
        junctions. A relatively smaller numbers of reads and alignments for WT samples 1 and 2 are not a matter of concern as FPKM
        normalization was used to assess the transcript isoform expression. WT=wild type. PF=pass filter
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3037Figure 1. Flowchart of RNA-seq data analysis methodology using Burrows-Wheeler Aligner (BWA) and TopHat. Schematic representation
of two RNA-seq data analysis workflows and resulting views of the data generated. A: BWA workflow: Gapped alignments are performed
using the BWA algorithm against the mouse reference genome build mm9, and estimation of the expression of genes at the transcript isoform
level is performed by importing aligned reads into the Partek Genomics Suite using annotations provided by the University of California Santa
Cruz (UCSC) refflat.txt file. Transcripts expressed at low levels in all samples (<1 fragments per kilobase of exon model per million mapped
reads [FPKM]) are filtered out. Differential expression analysis was performed by applying the ANOVA (ANOVA) method, and the resulting
list was sorted and filtered into different transcript groups. Clustering of rod and cone enriched genes was performed using Cluster 3.0 software
(see Methods). B: TopHat workflow: Splice junction mapping was performed using the TopHat algorithm in two phases. In the first phase,
splice junctions were detected de novo from the reads from each sample and combined to obtain a master splice junctions list. In the second
phase of TopHat alignment, reads from each sample were re-aligned by providing the master junctions list as input. The two-phase mapping
approach significantly increased the number of alignments spanning the splice junctions. Estimation of gene expression and differential
expression were computed using Cufflinks, Cuffcompare, and Cuffdiff. Sorting and filtering of transcript isoforms were performed as in the
BWA workflow.
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3038upregulated  in  Nrl−/−  (including  cone-enriched  genes  and
those involved in retinal remodeling) retinas.
TopHat workflow: A total of 34,115 transcripts were detected
with a normalized FPKM value of greater than 1.0 in any of
the samples in either group. Transcripts were filtered based
on whether they were protein-coding mRNAs or ncRNAs. Of
the 32,001 mRNA transcripts, only 3,258 met our criteria of
differential expression (Table 4). The DETs represented 1990
unique genes; 1,504 were downregulated in Nrl−/− (including
rod-specific genes) retinas, and 1,754 were upregulated in the
Nrl−/− (including cone-enriched genes and those involved in
retinal remodeling) retinas.
Comparison of the results from BWA and TopHat analyses:
The  BWA/ANOVA  and  TopHat/Cufflinks  analyses  were
compared to assess the consistency and quality of the results.
Using the official Mouse Genome Informatics gene symbol
as  the  linking  term,  Venn  diagrams  were  constructed  to
summarize the overlap between the set of all (Figure 2A), the
top 500 (Figure 2B), and the top 200 (Figure 2C) DETs from
the  BWA  workflow  and  the  DET  list  from  the  TopHat
workflow. A comparison of the full list of BWA DETs to the
TopHat  list  revealed  only  51.7%  overlap  between  the
differentially  expressed  genes  (DEGs)  from  BWA  and
TopHat. This overlap increased to 73.8% and 87.8% when
only the top 500 and 200 DEGs from BWA, respectively, were
considered. Subsequent analyses were performed using BWA
data.
Regression  analysis  of  quantitative  expression  values
obtained with RNA-seq and TaqMan qRT–PCR assays: We
first  assessed  the  correlation  between  the  FPKM  values
(obtained with RNA-seq) with their corresponding qRT–PCR
crossing threshold (Ct) values from the TaqMan assays; the
two values represent the quantitative levels of expression of a
specific transcript in the RNA sample. For this purpose, we
chose 24 differentially expressed genes (DEGs, reflecting a
wide  range  of  expression)  and  12  housekeeping  genes
(HKGs). The Ct values from three biologic replicates (without
normalization) were then compared to the corresponding log2
FPKM values (Figure 3). A least-squares regression analysis
of DEGs provided an R2 value of 0.8798, with a corresponding
slope  of  −1.056,  suggesting  a  strong  inverse  relationship
between Ct and log2 FPKM values over a dynamic range of
4–5 orders of magnitude. Only one out of 24 genes, cell
adhesion molecule 3 (Cadm3), fell outside this correlation.
Further investigation of the RNA-seq aligned reads showed
that our qRT–PCR assay was specific for only one of the two
retina-expressed spliced isoforms of Cadm3. The reanalysis
using a SYBR assay designed to detect both Cadm3 transcripts
confirmed the linear correlation between RNA-seq and qRT–
PCR analysis. Interestingly, FPKM and Ct values for 6 of the
12 HKGs did not show the expected linear relationship; these
included ubiquitin C (Ubc), ActB, ribosomal protein L13A
(Rpl13a), ribosomal protein S26 (Rps26), phosphoglycerate
kinase  1  (Pgkl),  and  most  severely  glyceraldehyde-3-
phosphate dehydrogenase (Gapdh). With the exception of
Ubc  that  was  underestimated  by  qRT–PCR  (in  the  same
manner as Cadm3), the BWA workflow underestimated all
others.
A  comparison  of  RNA-seq  and  qRT–PCR  data  for
housekeeping genes: RNA-seq data were evaluated for the
expression of 27 established HKGs (Table 5) included in the
control qRT–PCR plates from the following vendors: Life
Technologies  (Mouse  Endogenous  Control  Array),  SA
Biosciences,  Frederick,  MD  (Mouse  Housekeeping  Genes
RT2  Profiler  PCR  Array),  and  Qiagen,  Valencia,  CA
(QuantiTect Housekeeping Genes). Comparison of qRT–PCR
data for 12 genes (that were tested) showed almost complete
concordance of expression with the RNA-seq results. Only
one gene, Ubc, revealed a significant difference in expression
between the WT and Nrl−/− retinas with qRT–PCR (−1.89
fold)  compared  to  the  RNA-seq  (−1.19  fold)  analyses.
Gapdh showed a relatively high change in expression in qRT–
PCR  and  RNA-seq  (−1.49  and  −1.37  fold,  respectively).
Hprt and Rpl13a revealed lower variation in qRT–PCR and
RNA-seq,  respectively.  Actb,  TATA  box  binding  protein
(Tbp), glucuronidase, beta (Gusb), and Pgk1 were among the
best HKGs for qRT–PCR and RNA-seq normalization. For
further qRT–PCR analyses, we employed ActB and Hprt in
all normalization calculations.
TABLE 4. SUMMARY OF TRANSCRIPT ISOFORMS DETECTED BY BWA/ANOVA AND TOPHAT/CUFFLINKS WORKFLOWS
Analysis BWA/ANOVA TopHat/Cufflinks
Total detected transcripts 16,014 34,115
mRNA 15,142 32,001
mRNA DETs 1,422 3,258
        The BWA workflow employed refflat.txt annotation for mouse build mm9 from UCSC genome browser. The TopHat workflow
        employed GTF annotation for mouse build mm9 from the Ensembl database. After FPKM filtering (see Materials and Methods),
        transcribed features were classified as protein coding mRNAs and non-coding (nc) RNAs. The features classified as protein-
        coding mRNAs were further filtered based on fold change (≥1.5) and p-value (<0.05) to be considered significantly differentially
        expressed transcripts (DETs).
Molecular Vision 2011; 17:3034-3054 <http://www.molvis.org/molvis/v17/a327> © 2011 Molecular Vision
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Based on the RNA-seq data from the WT and Nrl−/− retinas,
we selected 25 DEGs (12 downregulated and 13 upregulated)
showing a wide range of differential expression for validation
with  qRT–PCR  analysis.  qRT–PCR  data  for  all  genes
validated  the  RNA-seq  results  (Figure  4).  The  WNT1
inducible signaling pathway protein 1 (Wisp1) TaqMan assay
did  not  produce  an  amplicon  in  any  of  the  experiments
performed;  subsequent  examination  of  the  RNA-seq  data
revealed that this assay did not correspond to the splice variant
expressed in the retina. Additional analysis using a SYBR
assay  with  oligonucleotides  specific  to  the  retinal  splice
variant confirmed the differential expression of Wisp1 (−43.9
fold change) in the Nrl−/− retina compared to the WT.
Expression levels of transcripts in the WT and Nrl−/− retina:
The  preceding  analysis  clearly  demonstrates  the  high
reliability and accuracy of the data obtained with RNA-seq
methodology.  We  therefore  used  RNA-seq  data  to  derive
absolute expression levels of individual transcripts. The top
25 genes highly expressed in the WT or Nrl−/− retina are listed
in Table 6 and Table 7. As predicted, most of these genes
encode  proteins  involved  in  photoreceptor  function/
metabolism.
Rod and cone photoreceptor enriched genes: We then focused
on DEGs between the Nrl−/− and WT retinas. A total of 1,422
transcripts, corresponding to 1,218 unique genes, showed a
minimum fold change of 1.5 at p≤0.05. Hierarchical clustering
of  all  differentially  expressed  transcripts  resulted  in  two
distinct clusters: one cluster of 477 genes downregulated in
the Nrl−/− retina includes all known rod-specific genes such as
rhodopsin  (Rho;  FC=-4,804),  guanine  nucleotide  binding
protein, alpha transducing 1 (Gnat1; FC=-2,034), and nuclear
receptor subfamily 2, group E, member 3 (Nr2e3; FC=-227.5;
Figure  5A  and  Table  8);  and  the  other  cluster  of  741
upregulated genes had all cone-specific genes such as opsin
1,  short-wave-sensitive  (Opn1sw;  FC=18.4),  cyclic
nucleotide  gated  channel  beta  3  (Cngb3;  FC=18.1),  and
Gnat2 (FC=12.2; Figure 5B and Table 9).
We  then  compared  our  DEG  list  with  two  published
studies  that  examined  WT  and  Nrl−/−  retinas:  a  recent
transcript-level RNA-seq analysis that included 6,123 DETs
[54] and a gene-level microarray analysis showing 438 DEGs
[38] (Figure 6). To obtain the list of DEGs from the Mustafi
et al. [55] data set, we performed ANOVA on their FPKM
data from GEO database. Interestingly, the DEGs lists from
the three studies had only 203 common genes including many
previously  identified  genes  specifically  expressed  in  cone
(fatty  acid  binding  protein  7,  brain  [Fabp7],  Opn1sw,
Cngb3, and Gnat2) or rod (Rho, Gnat1, cyclic nucleotide
gated channel alpha 1 [Cnga1], and Nr2e3) photoreceptors.
To assess the power of RNA-seq to more comprehensively
identify DETs than microarray, we examined the list of 634
Figure  2.  Venn  diagrams  comparing
differentially  expressed  transcripts
(DETs)  between  the  Nrl−/−  and  WT
groups  from  BWA  and  TopHat
analyses. Despite major differences in
the UCSC refFlat annotations used by
Burrows-Wheeler Aligner (BWA) and
Ensembl annotations used by TopHat,
most of the genes identified by BWA
were  also  identified  as  significant  by
TopHat.  A:  Comparison  of  the  total
number  of  DETs  identified  as
significant  (fold  change  ≥1.5  and  p-
value <0.05) by the two methods. B:
Inclusion  of  the  top  500  DETs  (424
unique genes) identified as significant
by BWA and in the full TopHat DET
list. C: Inclusion of the top 200 DETs
(179  unique  genes)  identified  as
significant  by  BWA  and  in  the  full
TopHat  DET  list.  We  assess  the  two
methods based on a comparison of qRT–
PCR  data  for  the  genes  detected  by
either or both methods. The discrepancy
between the results can be attributed to
differences in the input annotation files
used  (UCSC  refFlat  versus  Ensembl
GTF)  by  the  two  methods  and  their
alignment algorithms.
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3040genes identified in common by the RNA-seq studies but not
by the microarray study. This list included 18 retinal disease
genes (ATP-binding cassette, sub-family A (ABC1), member
4  [Abca4],  cadherin  23  (otocadherin)  [Cdh23],  ADP-
ribosylation factor-like 6 [Arl6], Bardet-Biedl syndrome 9
(human) [Bbs9], calcium binding protein 4 [Cabp4], cyclic
nucleotide gated channel alpha 3 [Cnga3], G protein-coupled
receptor 98 [Gpr98], guanylate cyclase activator 1a (retina)
[Guca1a], opsin 1 (cone pigments), medium-wave-sensitive
(color blindness, deutan) [Opn1mw], orthodenticle homolog
2  (Drosophila)  [Otx2],  phosphodiesterase  6G,  cGMP-
specific, rod, gamma [Pde6g], peripherin 2 [Prph2], retinol
binding protein 4, plasma [Rbp4], retinol dehydrogenase 1 (all
trans)  [Rdh1],  regulator  of  G-protein  signaling  9  binding
protein [Rgs9bp], unc-119 homolog (C. elegans) [Unc119],
Usher syndrome 2A (autosomal recessive, mild) homolog
(human) [Ush2a], and whirlin [Whrn]) and several known
genes involved in visual perception (guanylate cyclase 2e
[Gucy2e], guanylate cyclase 2f [Gucy2f], recoverin [Rcvrn],
RAR-related  orphan  receptor  beta  [Rorb],  and  sal-like  3
(Drosophila)  [Sall3]).  Several  genes  showing  large
differential  expression  values  might  participate  in  rod
homeostasis (galactosidase, beta 1-like 2 [Glb1l2] FC=-14.02,
GRAM  domain  containing  2  [Gramd2]  FC=-14.0,
carbohydrate  (chondroitin  6/keratan)  sulfotransferase  3
[Chst3] FC=-4.8, desert hedgehog [Dhh] FC=-4.1, and ADP-
ribosylation  factor-like  4D  [Arl4d]  FC=-3.6)  and  cone
function (dual specificity phosphatase 23 [Dusp23] FC=6.3,
cyclin-dependent  kinase  11B  [Cdkl1]  FC=6.1,  tryptophan
hydroxylase  1  [Tph1]  FC=4.7,  muscle  glycogen
phosphorylase  [Pygm]  FC=4.6,  cyclin-dependent  kinase  6
[Cdk6] FC=4.0, Sall3 FC=3.9, and early growth response 1
[Egr1] FC=3.7).
Our RNA-seq data allowed us to identify 359 genes not
identified in previous investigations. To further assess the
quality of our analysis, we performed qRT–PCR validation of
15 genes identified by other studies (but not in our study) as
differentially expressed and of 7 genes uniquely identified by
our study (but not by other studies; Table 10). Of the 15 genes
identified by other studies, only three (ATP-binding cassette,
sub-family A (ABC1), member 13 [Abca13], CD8 antigen,
alpha chain [Cd8a], and acyl-CoA oxidase-like [Acoxl]) were
confirmed with qRT–PCR as being differentially expressed.
We also detected these three as differentially expressed but
had filtered them out because of FPKM values that were less
than 1.0 in all samples. Interestingly, the Abca13 transcript
detected in the retina had only sequence reads for exons 56
through 62. This finding was supported by qRT–PCR using
two SYBR assays designed to exons 53/55 and exons 56/58.
All  seven  genes  uniquely  identified  by  our  study  were
validated as significantly differentially expressed.
The significantly lower number of DETs detected by our
study compared to the Mustafi et al. study (2011; 1,422 versus
6,123, respectively) can be attributed to the following:
1. We used a stringent 1.0 FPKM cutoff that generated a
list of genes with significant base level expression and fewer
false positives than a lower expression level threshold. If we
had decreased our threshold to 0.1 FPKM, we would have
detected 975 more DETs; however, these genes are expressed
at an extremely low level and their impact must be weighed
against  the  increase  in  false  positives.  We  chose  a
Figure 3. Correlation of RNA-seq and
qRT–PCR.  The  correlations  between
the RNA-seq fragments per kilobase of
exon model per million mapped reads
(FPKM) values and the corresponding
qRT–PCR  crossing  threshold  (Ct)
values  are  shown.  FPKM  values
represented  in  log2  scale,  and  non-
normalized Ct values are an average of
three biologic replicates. Data generated
from  differentially  expressed  genes
(black) is contrasted with data generated
from the housekeeping genes (red). The
dashed  line,  associated  equation,  and
goodness of fit value were generated by
least-squares regression analysis of the
differentially expressed data set. Since a
lower Ct value indicates an increased
initial  amount  of  target  mRNA,  an
inverse relationship between FPKM and
Ct values is expected if a correlation
exists.
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3042conservative criterion to identify significant and bona fide
differentially expressed genes.
2.  Mustafi  et  al.  [54]  pooled  multiple  RNA  samples
before generating the library and used the identical library on
multiple  lanes  of  the  sequencer.  Our  experimental  design
consisted  of  libraries  generated  from  individual  biologic
replicates that allowed us to eliminate the transcripts based on
p-value.
Several  DETs  we  identified  might  contribute  to
photoreceptor function but are not yet characterized; these
include  pleckstrin  homology  domain  containing,  family  F
(with FYVE domain) member 2 (Plekhf2; FC=-5.35), kelch-
like 13 (Drosophila) [Klhl3] (FC=-3.3), NIPA-like domain
containing  1  (Nipal1;  FC=-2.8),  and  coiled-coil  domain
containing 24 (Ccdc24; FC=-2.6) in the WT retina, and kelch-
like  33  (Drosophila)  [Klhl33]  (FC=14),  WSC  domain
containing  2  (Wscd2;  FC=4),  hairless  (Hr;  FC=3.9)  and
regulator of G-protein signaling 22 (Rgs22; FC=3.8) in the
Nrl−/− retina. We also identified Crx opposite strand transcript
1 (Crxos1; FC=4.1), which is exclusively expressed in the eye
from the opposite strand of a key retinal transcription factor,
cone-rod  homeobox  containing  gene  (Crx)  [55].  An
interesting new finding is the retinal expression of multiple
genes from the Kelch-like family (Klhl3, 4, 5, 18, 33, 36),
solute carrier family (>30 members), and zinc-finger protein
family (>10 members). Mutations in at least one gene from
each  family  have  previously  been  associated  with  retinal
disease: Klhl7 with autosomal dominant RP [56], Slc24A1
with  autosomal-recessive  congenital  stationary  night
blindness [57], and Znf513 with autosomal-recessive retinitis
pigmentosa (RP) [58].
DISCUSSION
Specific patterns of gene expression define the morphology
and function of distinct cell types and tissues. Changes in gene
expression are associated with complex biologic processes,
including  development,  aging,  and  disease  pathogenesis.
Until recently, such investigations focused on one or a few
genes  at  a  time.  Advances  in  genomic  technology  have
permitted simultaneous evaluation of most, if not all, genes
that respond to an extrinsic microenvironment or intrinsic
biologic program(s). Such studies are critical for delineating
gene  networks  that  can  be  targeted  for  treating  specific
diseases.  RNA-seq  allows  comprehensive  evaluation  of
transcriptomes,  alternative  transcripts,  and  coding
polymorphisms. However, analyzing RNA-seq data has been
challenging due to the complexity associated with quality
control, sequence alignments, and handling of large data sets
[59].  Several  algorithms  [45,60]  have  been  proposed  for
mapping  sequence  reads  to  the  reference  genome,  and
multiple  workflows  [16,50]  suggested  for  RNA-seq  data
analysis. Here, we report a detailed RNA-seq methodology
using WT and Nrl−/− retinas as a study paradigm and establish
the  high  performance  of  NGS  technology  compared  to
microarray  and  qRT–PCR  platforms  for  transcript
identification  and  quantification  studies.  Consistent  with
recent  studies  [61],  our  RNA-seq  data  demonstrate  high
sensitivity, a wider dynamic range of coverage, and lower
technical variability.
Quantitative RT–PCR has long been considered the “gold
standard”  for  mRNA  quantification  [62,63],  and  hence
routinely used to validate results from transcriptome analysis
studies. We show that FPKM values from RNA-seq analysis
have a strong linear correlation across at least four orders of
magnitude  with  Ct  values  from  qRT–PCR.  Expression  of
Figure 4. qRT–PCR validation of RNA-
seq results. Comparison of differential
expression values determined by RNA-
seq  (dark  gray)  and  qRT–PCR  (light
gray)  for  25  differentially  expressed
genes  identified  by  Burrows-Wheeler
Aligner  (BWA)  workflow.  Error  bars
represent the standard error of the mean.
Neural retina leucine zipper gene (Nrl)
was  not  detectable  by  qRT–PCR  and
therefore  are  left  blank  in  the  graph.
Note  that  Rhodopsin  (Rho),  guanine
nucleotide  binding  protein,  alpha
transducing 1 (Gnat1), cyclic nucleotide
gated  channel  alpha  1  (Cnga1),  and
nuclear receptor subfamily 2, group E,
member  3  (Nr2e3)  having  average
crossing  threshold  (Ct)  values  greater
than  30  in  the  Nrl−/−  samples  are
considered  extremely  low  to  non-
expressing.
Molecular Vision 2011; 17:3034-3054 <http://www.molvis.org/molvis/v17/a327> © 2011 Molecular Vision
3043T
A
B
L
E
 
6
.
 
T
O
P
 
2
5
 
H
I
G
H
L
Y
 
E
X
P
R
E
S
S
E
D
 
T
R
A
N
S
C
R
I
P
T
S
 
I
N
 
W
I
L
D
-
T
Y
P
E
 
R
E
T
I
N
A
 
B
A
S
E
D
 
O
N
 
R
N
A
-
S
E
Q
 
D
A
T
A
.
T
r
a
n
s
c
r
i
p
t
 
I
D
G
e
n
e
 
I
D
G
e
n
e
 
n
a
m
e
W
T
 
F
P
K
M
N
r
l
−
/
−
 
F
P
K
M
N
M
_
1
4
5
3
8
3
R
h
o
R
h
o
d
o
p
s
i
n
8
1
3
5
.
4
1
.
7
N
M
_
0
0
8
1
4
0
G
n
a
t
1
G
u
a
n
i
n
e
 
n
u
c
l
e
o
t
i
d
e
 
b
i
n
d
i
n
g
 
p
r
o
t
e
i
n
 
γ
 
t
r
a
n
s
d
u
c
i
n
g
 
a
c
t
i
v
i
t
y
 
p
o
l
y
p
e
p
t
i
d
e
 
1
4
0
1
1
.
7
2
N
M
_
0
0
8
9
3
8
P
r
p
h
2
P
e
r
i
p
h
e
r
i
n
 
2
1
4
4
8
.
2
3
6
7
.
1
N
M
_
0
1
2
0
6
5
P
d
e
6
g
P
h
o
s
p
h
o
d
i
e
s
t
e
r
a
s
e
 
6
G
 
c
G
M
P
-
s
p
e
c
i
f
i
c
 
r
o
d
 
γ
1
2
6
9
.
5
5
5
2
.
6
N
M
_
0
0
9
0
7
3
R
o
m
1
R
e
t
i
n
a
l
 
o
u
t
e
r
 
s
e
g
m
e
n
t
 
m
e
m
b
r
a
n
e
 
p
r
o
t
e
i
n
 
1
9
4
8
.
8
2
2
9
.
1
N
M
_
0
1
5
7
4
5
R
b
p
3
R
e
t
i
n
o
l
 
b
i
n
d
i
n
g
 
p
r
o
t
e
i
n
 
3
8
8
5
.
3
1
0
2
4
N
M
_
0
0
9
1
1
8
S
a
g
S
-
a
n
t
i
g
e
n
 
r
e
t
i
n
a
 
a
n
d
 
p
i
n
e
a
l
 
g
l
a
n
d
7
6
5
.
4
5
4
8
.
7
N
M
_
0
1
1
6
7
6
U
n
c
1
1
9
U
n
c
-
1
1
9
 
h
o
m
o
l
o
g
7
1
9
.
1
4
0
7
.
3
N
M
_
0
2
4
4
5
8
P
d
c
P
h
o
s
d
u
c
i
n
6
8
9
.
8
3
0
2
.
3
N
M
_
0
0
9
0
3
8
R
c
v
r
n
R
e
c
o
v
e
r
i
n
6
4
3
.
6
2
8
8
N
M
_
0
1
1
0
9
9
P
k
m
2
P
y
r
u
v
a
t
e
 
k
i
n
a
s
e
 
m
u
s
c
l
e
6
0
4
.
7
4
6
7
.
9
N
M
_
0
0
1
1
5
9
7
3
0
P
d
c
P
h
o
s
d
u
c
i
n
5
8
0
2
5
0
.
7
N
M
_
1
4
6
0
7
9
G
u
c
a
1
b
G
u
a
n
y
l
a
t
e
 
c
y
c
l
a
s
e
 
a
c
t
i
v
a
t
o
r
 
1
B
5
5
2
.
6
6
8
.
1
N
M
_
0
0
8
1
3
1
G
l
u
l
G
l
u
t
a
m
a
t
e
-
a
m
m
o
n
i
a
 
l
i
g
a
s
e
5
4
5
5
3
0
.
1
N
M
_
0
0
1
1
3
6
0
7
4
N
r
l
N
e
u
r
a
l
 
r
e
t
i
n
a
 
l
e
u
c
i
n
e
 
z
i
p
p
e
r
5
4
5
1
.
9
N
M
_
0
0
1
1
6
0
0
1
7
G
n
b
1
G
u
a
n
i
n
e
 
n
u
c
l
e
o
t
i
d
e
 
b
i
n
d
i
n
g
 
p
r
o
t
e
i
n
 
β
 
p
o
l
y
p
e
p
t
i
d
e
 
1
4
8
7
.
8
2
4
.
4
N
M
_
0
1
1
4
2
8
S
n
a
p
2
5
S
y
n
a
p
t
o
s
o
m
a
l
-
a
s
s
o
c
i
a
t
e
d
 
p
r
o
t
e
i
n
 
2
5
 
k
D
a
4
7
1
.
1
5
7
6
N
M
_
1
4
6
0
8
6
P
d
e
6
a
R
o
d
 
p
h
o
t
o
r
e
c
e
p
t
o
r
 
c
G
M
P
 
p
h
o
s
p
h
o
d
i
e
s
t
e
r
a
s
e
 
a
 
s
u
b
u
n
i
t
4
3
3
.
5
3
5
.
8
N
M
_
0
2
6
3
5
8
4
9
3
0
5
8
3
H
1
4
R
i
k
U
n
k
n
o
w
n
4
0
7
.
3
3
6
2
N
M
_
0
1
3
4
1
5
A
t
p
1
b
2
A
T
P
a
s
e
 
N
a
+
K
+
 
t
r
a
n
s
p
o
r
t
i
n
g
 
β
 
2
 
p
o
l
y
p
e
p
t
i
d
e
3
6
9
.
6
6
0
8
.
9
N
M
_
1
4
4
9
2
1
A
t
p
1
a
3
Α
 
3
 
s
u
b
u
n
i
t
 
o
f
 
N
a
+
K
+
 
A
T
P
a
s
e
3
6
7
.
1
2
8
6
N
M
_
0
0
8
8
0
6
P
d
e
6
b
P
h
o
s
p
h
o
d
i
e
s
t
e
r
a
s
e
 
6
B
 
c
G
M
P
-
s
p
e
c
i
f
i
c
 
r
o
d
 
β
3
6
4
.
6
1
6
.
2
N
M
_
0
0
1
1
6
0
0
1
6
G
n
b
1
G
u
a
n
i
n
e
 
n
u
c
l
e
o
t
i
d
e
 
b
i
n
d
i
n
g
 
p
r
o
t
e
i
n
 
β
 
p
o
l
y
p
e
p
t
i
d
e
 
1
3
5
2
.
1
1
8
.
1
 
(
i
s
o
f
o
r
m
 
2
)
 
 
 
N
M
_
0
0
8
1
4
2
G
n
b
1
G
u
a
n
i
n
e
 
n
u
c
l
e
o
t
i
d
e
 
b
i
n
d
i
n
g
 
p
r
o
t
e
i
n
 
β
 
p
o
l
y
p
e
p
t
i
d
e
 
1
3
4
9
.
7
1
7
.
9
 
(
i
s
o
f
o
r
m
 
1
)
 
 
 
N
M
_
0
1
0
3
1
4
G
n
g
t
1
G
u
a
n
i
n
e
 
n
u
c
l
e
o
t
i
d
e
 
b
i
n
d
i
n
g
 
p
r
o
t
e
i
n
 
g
 
t
r
a
n
s
d
u
c
i
n
g
 
a
c
t
i
v
i
t
y
 
p
o
l
y
p
e
p
t
i
d
e
 
1
3
4
0
.
1
2
0
3
.
7
 
 
 
 
 
 
 
 
 
 
A
s
 
p
h
o
t
o
r
e
c
e
p
t
o
r
s
 
c
o
n
s
t
i
t
u
t
e
 
a
l
m
o
s
t
 
7
0
%
 
o
f
 
c
e
l
l
s
 
i
n
 
P
2
1
 
W
T
 
a
n
d
 
N
r
l
−
/
−
 
r
e
t
i
n
a
,
 
t
h
e
 
h
i
g
h
 
e
x
p
r
e
s
s
e
d
 
g
e
n
e
s
 
(
i
n
 
b
o
l
d
)
 
l
i
k
e
l
y
 
e
n
c
o
d
e
 
p
r
o
t
e
i
n
s
 
a
s
s
o
c
i
a
t
e
d
 
w
i
t
h
 
g
e
n
e
r
a
l
 
 
 
 
 
 
 
 
 
 
 
p
h
o
t
o
r
e
c
e
p
t
o
r
 
f
u
n
c
t
i
o
n
/
m
e
t
a
b
o
l
i
s
m
.
 
W
T
=
w
i
l
d
 
t
y
p
e
Molecular Vision 2011; 17:3034-3054 <http://www.molvis.org/molvis/v17/a327> © 2011 Molecular Vision
3044T
A
B
L
E
 
7
.
 
T
O
P
 
2
5
 
H
I
G
H
L
Y
 
E
X
P
R
E
S
S
E
D
 
T
R
A
N
S
C
R
I
P
T
S
 
I
N
 
N
R
L
−
/
−
 
R
E
T
I
N
A
 
B
A
S
E
D
 
O
N
 
R
N
A
-
S
E
Q
 
D
A
T
A
.
T
r
a
n
s
c
r
i
p
t
 
I
D
G
e
n
e
 
I
D
G
e
n
e
 
n
a
m
e
W
T
 
F
P
K
M
N
r
l
−
/
−
 
F
P
K
M
N
M
_
0
0
7
5
3
8
O
p
n
1
s
w
O
p
s
i
n
 
1
 
s
h
o
r
t
-
w
a
v
e
-
s
e
n
s
i
t
i
v
e
1
4
9
.
1
2
7
4
0
.
1
N
M
_
0
1
5
7
4
5
R
b
p
3
R
e
t
i
n
o
l
 
b
i
n
d
i
n
g
 
p
r
o
t
e
i
n
 
3
8
8
5
.
3
1
0
2
4
N
M
_
0
0
8
1
4
1
G
n
a
t
2
G
u
a
n
i
n
e
 
n
u
c
l
e
o
t
i
d
e
 
b
i
n
d
i
n
g
 
p
r
o
t
e
i
n
 
a
 
t
r
a
n
s
d
u
c
i
n
g
 
2
7
0
.
5
8
6
1
.
1
N
M
_
0
1
3
5
3
0
G
n
b
3
G
u
a
n
i
n
e
 
n
u
c
l
e
o
t
i
d
e
 
b
i
n
d
i
n
g
 
p
r
o
t
e
i
n
 
β
 
p
o
l
y
p
e
p
t
i
d
e
 
3
1
0
3
.
3
7
8
6
.
9
N
M
_
1
3
3
2
0
5
A
r
r
3
A
r
r
e
s
t
i
n
 
3
,
 
r
e
t
i
n
a
l
6
9
.
6
6
5
2
.
6
N
M
_
0
2
3
8
9
8
P
d
e
6
h
P
h
o
s
p
h
o
d
i
e
s
t
e
r
a
s
e
 
6
H
 
c
G
M
P
-
s
p
e
c
i
f
i
c
 
c
o
n
e
 
g
9
1
.
1
6
3
4
.
7
N
M
_
0
1
3
4
1
5
A
t
p
1
b
2
A
T
P
a
s
e
 
N
a
+
K
+
 
t
r
a
n
s
p
o
r
t
i
n
g
 
β
 
2
 
p
o
l
y
p
e
p
t
i
d
e
3
6
9
.
6
6
0
8
.
9
N
M
_
0
1
1
4
2
8
S
n
a
p
2
5
S
y
n
a
p
t
o
s
o
m
a
l
-
a
s
s
o
c
i
a
t
e
d
 
p
r
o
t
e
i
n
 
2
5
 
k
D
a
4
7
1
.
1
5
7
6
N
M
_
0
1
2
0
6
5
P
d
e
6
g
P
h
o
s
p
h
o
d
i
e
s
t
e
r
a
s
e
 
6
G
 
c
G
M
P
-
s
p
e
c
i
f
i
c
 
r
o
d
 
g
1
2
6
9
.
5
5
5
2
.
6
N
M
_
0
0
9
1
1
8
S
a
g
S
-
a
n
t
i
g
e
n
 
r
e
t
i
n
a
 
a
n
d
 
p
i
n
e
a
l
 
g
l
a
n
d
7
6
5
.
4
5
4
8
.
7
N
M
_
0
0
8
1
3
1
G
l
u
l
G
l
u
t
a
m
a
t
e
-
a
m
m
o
n
i
a
 
l
i
g
a
s
e
5
4
5
5
3
0
.
1
N
M
_
0
5
3
2
4
5
A
i
p
l
1
A
r
y
l
 
h
y
d
r
o
c
a
r
b
o
n
 
r
e
c
e
p
t
o
r
 
i
n
t
e
r
a
c
t
i
n
g
 
p
r
o
t
e
i
n
-
l
i
k
e
 
1
3
1
3
5
1
5
.
6
N
M
_
0
0
9
3
0
5
S
y
p
S
y
n
a
p
t
o
p
h
y
s
i
n
3
2
6
.
3
5
0
5
N
M
_
0
0
8
1
8
9
G
u
c
a
1
a
G
u
a
n
y
l
a
t
e
 
c
y
c
l
a
s
e
 
a
c
t
i
v
a
t
o
r
 
1
A
 
(
r
e
t
i
n
a
)
3
0
6
.
6
4
8
7
.
8
N
M
_
0
1
1
0
9
9
P
k
m
2
P
y
r
u
v
a
t
e
 
k
i
n
a
s
e
 
m
u
s
c
l
e
6
0
4
.
7
4
6
7
.
9
N
M
_
0
1
3
4
9
4
C
p
e
C
a
r
b
o
x
y
p
e
p
t
i
d
a
s
e
 
E
3
3
7
.
8
4
3
9
.
6
N
M
_
0
2
3
1
2
1
G
n
g
t
2
G
u
a
n
i
n
e
 
n
u
c
l
e
o
t
i
d
e
 
b
i
n
d
i
n
g
 
p
r
o
t
e
i
n
 
g
 
t
r
a
n
s
d
u
c
i
n
g
 
a
c
t
i
v
i
t
y
 
p
o
l
y
p
e
p
t
i
d
e
 
2
3
2
4
0
7
.
3
N
M
_
0
1
1
6
7
6
U
n
c
1
1
9
U
n
c
-
1
1
9
 
h
o
m
o
l
o
g
7
1
9
.
1
4
0
7
.
3
N
M
_
0
2
1
2
7
3
C
k
b
C
r
e
a
t
i
n
e
 
k
i
n
a
s
e
 
b
r
a
i
n
2
9
0
3
9
8
.
9
N
M
_
0
0
7
4
5
0
S
l
c
2
5
a
4
S
o
l
u
t
e
 
c
a
r
r
i
e
r
 
f
a
m
i
l
y
 
2
5
 
m
e
m
b
e
r
 
4
3
1
3
3
8
5
.
3
N
M
_
0
0
8
9
3
8
P
r
p
h
2
P
e
r
i
p
h
e
r
i
n
 
2
1
4
4
8
.
2
3
6
7
.
1
N
M
_
0
2
6
3
5
8
4
9
3
0
5
8
3
H
1
4
R
i
k
U
n
k
n
o
w
n
4
0
7
.
3
3
6
2
N
M
_
0
1
6
7
7
4
A
t
p
5
b
A
T
P
 
s
y
n
t
h
a
s
e
 
H
+
 
t
r
a
n
s
p
o
r
t
i
n
g
 
m
i
t
o
c
h
o
n
d
r
i
a
l
 
F
1
 
c
o
m
p
l
e
x
 
β
 
p
o
l
y
p
e
p
t
i
d
e
3
1
5
.
2
3
5
2
.
1
N
M
_
0
0
1
0
3
8
6
6
4
G
n
g
t
2
G
u
a
n
i
n
e
 
n
u
c
l
e
o
t
i
d
e
 
b
i
n
d
i
n
g
 
p
r
o
t
e
i
n
 
γ
 
t
r
a
n
s
d
u
c
i
n
g
 
a
c
t
i
v
i
t
y
 
p
o
l
y
p
e
p
t
i
d
e
 
2
2
2
.
6
3
3
7
.
8
N
M
_
0
1
0
1
0
6
E
e
f
1
a
1
E
u
k
a
r
y
o
t
i
c
 
t
r
a
n
s
l
a
t
i
o
n
 
e
l
o
n
g
a
t
i
o
n
 
f
a
c
t
o
r
 
1
 
α
 
1
2
6
5
3
2
8
.
6
 
 
 
 
 
 
 
 
 
A
s
 
p
h
o
t
o
r
e
c
e
p
t
o
r
s
 
c
o
n
s
t
i
t
u
t
e
 
a
l
m
o
s
t
 
7
0
%
 
o
f
 
c
e
l
l
s
 
i
n
 
P
2
1
 
W
T
 
a
n
d
 
N
r
l
−
/
−
 
r
e
t
i
n
a
,
 
t
h
e
 
h
i
g
h
 
e
x
p
r
e
s
s
e
d
 
g
e
n
e
s
 
(
i
n
 
b
o
l
d
)
 
l
i
k
e
l
y
 
e
n
c
o
d
e
 
p
r
o
t
e
i
n
s
 
a
s
s
o
c
i
a
t
e
d
 
w
i
t
h
 
g
e
n
e
r
a
l
 
 
 
 
 
 
 
 
 
p
h
o
t
o
r
e
c
e
p
t
o
r
 
f
u
n
c
t
i
o
n
/
m
e
t
a
b
o
l
i
s
m
.
 
W
T
=
w
i
l
d
 
t
y
p
e
Molecular Vision 2011; 17:3034-3054 <http://www.molvis.org/molvis/v17/a327> © 2011 Molecular Vision
3045Figure 5. Heatmaps and hierarchical clusters of differentially expressed rod-specific genes and cone-specific genes or those involved in retinal
remodeling. Heatmaps with dendrograms of clusters of differentially expressed rod genes (A) and cone / retinal remodeling genes (B) by
applying hierarchical clustering. A filtered list of mRNA transcript isoforms was further revised for fold change ≥1.5 and p-value <0.05, and
duplicate gene symbol rows were deleted to retain the most expressed isoform as reflective of the gene. This list was used to generate the
heatmap and the master cluster. Specific clusters of rod specific genes and cone-specific or retinal remodeling genes were identified as clusters
containing known rod genes (e.g., Rhodopsin [Rho], guanine nucleotide binding protein, alpha transducing 1 [Gnat1], cyclic nucleotide gated
channel alpha 1 [Cnga1], and nuclear receptor subfamily 2, group E, member 3 [Nr2e3]) and cone genes (e.g., fatty acid binding protein 7,
brain [Fabp7], cyclic nucleotide gated channel alpha 3 [Cnga3], cyclic nucleotide gated channel beta 3 [Cngb3]). Columns 1, 2, and 3 are
wild-type samples, and columns 4, 5, and 6 are Nrl−/− samples.
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3048several HKGs is underestimated by RNA-seq because of the
algorithmic limitation associated with alignment of reads that
map to multiple genomic locations (paralogous sequences or
pseudogenes).  All  of  the  outlying  HKGs  inspected  had  a
lower-than-projected FPKM value due to varying numbers of
associated pseudogenes [64-67]. For example, Gapdh has 331
pseudogenes in the mouse genome [64]. Our qRT–PCR data
projected an FPKM value of approximately 4000 for Gapdh,
yet the BWA workflow estimated an FPKM of only 6.6 in the
WT retina (see Figure 3). This was also the case, but less
severe,  for  Pgk1,  Rps26,  Rpl13a,  and  ActB.  Current
algorithms proportionally divide the number of reads aligning
to  multiple  genes  during  FPKM  calculation  among  those
genes.  In  our  study,  unsuitable  qRT–PCR  assay  design
explains the remaining exceptions to the linear correlation
between  qRT–PCR  and  RNA-seq.  After  careful  visual
inspection of the aligned reads in IGV, we found that the assay
designed for Wisp1 was not specific to the splice variant
expressed in the retina. Similarly, the assays designed for
Cadm3 and Ubc were specific to one of the two transcripts
expressed in the retina. Hence, RNA-seq provides a better
assessment of alternate isoforms, and transcript quantification
is not limited by the design of qRT–PCR assays.
We took advantage of the RNA-seq data to inspect the
expression  of  commonly  used  HKGs  (see  Table  5)  for
normalization  in  qRT–PCR  assays.  The  choice  generally
depends on specific tissue and/or developmental time points
being investigated. Our RNA-seq studies suggest that most of
the HKGs can be used for normalization calculation in qRT–
PCR assays; however, Gapdh, β-2 microglobulin (B2m), and
Ubc do not appear to be good choices. Additional RNA-seq
data would help in delineating relevant HKGs appropriate for
qPCR validation in developing retina or cell types.
We compared two different strategies for analyzing WT
and Nrl−/− RNA-seq data. The BWA workflow relies on fast
and accurate gapped alignment of reads to the exonic regions
of the genome. Since the gap between most adjacent exons is
larger than a few bases, the cumulative gap extension penalty
underestimates the quality of the alignment of reads spanning
the splice junctions. Hence, the BWA workflow produced
accurate  quantitative  estimation  of  gene  and  transcript
isoform expression while losing valuable information about
Figure 6. Comparison of the current and
previous  data  sets  of  differentially
expressed  transcripts  of  Nrl−/−  versus
wild type (WT) mouse retina. Overlap
between  the  differentially  expressed
transcripts  (DETs)  identified  in  the
current study and previous studies using
mouse retinas from the same age and
genotype  was  determined  using  the
Mouse  Genome  Informatics  (MGI)
gene  symbol  as  the  identifier.  The
current  study  includes  all  mRNA
transcripts identified with the Burrows-
Wheeler  Aligner  (BWA)  workflow
(fold change ≥1.5 and p value <0.05).
The  438  DETs  of  an  Affymetrix
microarray study [38] and 6,123 DETs
from another RNA-seq study [54] with
similar  criteria  were  used  for
comparison with our study. Of the 438
DETs from the Corbo et al. [38] study,
157  transcripts  are  not  significantly
differentially expressed in our data, 11
are expressed below the fragments per
kilobase  of  exon  model  per  million
mapped  reads  (FPKM)  detection
threshold of 1.0, and 38 do not map to
the  current  annotations.  Of  the  6,123
DETs from the Mustafi et al. [54] study,
4,858  transcripts  are  not  significantly
differentially  expressed  in  our  study,
348  are  expressed  below  our  FPKM
detection threshold of 1.0, and 62 do not
map to the current annotations.
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3050alternate splicing. The higher accuracy of quantitative gene
expression estimates by the BWA workflow compared to
those  by  TopHat  is  evident  from  the  stronger  correlation
determined by linear regression analysis of the DETs. The
regression line from BWA had a slope of −1.056 (compared
to −0.905 for TopHat) and R2 of 0.8798 (compared to 0.7727
for TopHat).
The TopHat workflow maps the reads to exonic regions
of the reference genome as well as across all known and
putative splice junctions defined in the Ensembl GTF file.
TopHat attempts to map reads across splice junctions defined
in the Ensembl GTF file and across novel splice junctions
detected  during  the  first  phase  of  alignment.  Hence,  the
TopHat workflow maps significantly more reads starting with
the  same  number  of  pass  filter  (PF)  reads  and  detects
additional transcript isoforms missed by the BWA workflow.
The source of genomic annotations used by these methods is
another important difference. UCSC refFlat annotation (used
by  the  BWA  workflow)  for  the  mouse  reference  genome
(build  mm9)  contained  approximately  28,000  unique
transcript isoforms, whereas the Ensembl GTF file (used by
the TopHat workflow) for the same genome build listed three
times  more  unique  transcript  isoforms.  The  problem  is
amplified  because  of  the  lack  of  one-to-one  mapping  for
several transcripts defined in the UCSC refFlat file in Ensembl
GTF. Hence, a non-trivial number of DETs detected by the
BWA workflow could not be mapped to any DET from the
TopHat workflow (see Figure 2, regions shaded in green).
The BWA workflow detects about 16,000 transcripts in
the  retina,  with  a  minimum  expression  equivalent  to  one
transcript per cell (i.e., 1 FPKM) [16]. When the criteria were
relaxed  to  cover  transcripts  expressed  at  low  levels  (0.1
FPKM), 20,707 transcripts were detected in the retina. This is
not  surprising  as  the  whole  retina  includes  more  than  50
distinct  neuronal  cell  types,  and  each  cell  would  achieve
protein diversity largely by alternative promoter usage and/or
alternative  splicing  [68].  The  TopHat  workflow  yields
thousands  of  known  and  putative  transcript  isoforms  not
previously described in the retina. However, validating these
novel  isoforms  predicted  from  RNA-seq  data  remains  a
challenge.
Integrated analysis of RNA-seq data with miRNA-seq,
transcription  factor  binding  sites  data  (chromatin
immunoprecipitation  sequencing-Chip-Seq),  genetic
variations  (expression  Quantitative  Trait  Loci)  [69],  and
methylation patterns would allow decoding of the complex
regulatory networks associated with retinal development and
function. Several technical improvements would however be
necessary to overcome the bias introduced into the RNA-seq
data due to GC content, mappability of reads, length of the
gene, and regional differences due to local sequence structure
[70]. RNA-seq methods are more likely to identify longer
differentially  expressed  transcripts  than  shorter  transcripts
with the same effect size [71]. New statistical methods are
being developed to correct for systematic biases inherent in
NGS data [70-72]. In the coming years, we will witness an
explosion  in  high  throughput  genomic  methods  that  are
expected to revolutionize biology and biomedical discovery.
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